Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2007
06/12/2007CA2238410C Novel indole-2,3-dione-3-oxime derivatives
06/12/2007CA2198005C Pyrazolo[3,4-g]quinoxaline compounds which inhibit pdgf receptor protein tyrosine kinase
06/07/2007WO2007065100A1 Pyrrolotriazine kinase inhibitors
06/07/2007WO2007064993A2 Bicyclic protein kinase inhibitors
06/07/2007WO2007064842A2 Synthesis of chlorins and phorbines with enhanced red spectral features
06/07/2007WO2007064797A2 Inhibitors of c-met and uses thereof
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064045A1 Fused heterocyclic compound
06/07/2007WO2007063950A1 Long-wave fluorescent substance for diagnosis or treatment of conformation disease and use thereof
06/07/2007WO2007063935A1 Aromatic compound
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007WO2007063754A1 Compound for organic electroluminescent element and organic electroluminescent element
06/07/2007WO2007063013A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007WO2007063010A1 Novel vinylogous acids derivatives
06/07/2007WO2007062998A1 3-amino-2-arylpropyl azaindoles and uses thereof
06/07/2007WO2007062805A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS
06/07/2007WO2007044426A3 Pyrazolopyrimidines as protein kinase inhibitors
06/07/2007WO2007044401A3 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/07/2007WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
06/07/2007WO2006127287A3 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
06/07/2007WO2006024640A3 Triazolophthalazines
06/07/2007US20070129547 Process to prepare substituted imidazopyrazine compounds
06/07/2007US20070129542 Process for making 5,11-Dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
06/07/2007US20070129541 Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
06/07/2007US20070129397 Ester derivatives
06/07/2007US20070129383 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof
06/07/2007US20070129382 Crf receptor antagonists, their preparations, their pharmaceutical composition, and their uses
06/07/2007US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070129372 2-substituted-5-phenyl pyrido[1,2-b]pyridizin-6-ones; antiinflammatory agents for conditions related to arthritis, eczema, psoriasis, sunburns, conjunctivitis, pyresis, and pain
06/07/2007US20070129366 Methods for the treatment of chronic pain and compositions therefor
06/07/2007US20070129353 Alpha-helix mimetics and method relating to the treatment of cancer stem cells
06/07/2007US20070128658 Fluorescent dyes, methods and uses thereof
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632284A1 3-amino-2-arylpropyl azaindoles and uses thereof
06/07/2007CA2631232A1 Novel vinylogous acids derivatives
06/07/2007CA2631066A1 Fused heterocyclic compound
06/07/2007CA2630884A1 Inhibitors of c-met and uses thereof
06/07/2007CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007CA2630164A1 3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as ephb and vegfr2 kinase inhibitors
06/06/2007EP1791843A2 Monocyclic anilide spirolactam cgrp receptor antagonists
06/06/2007EP1791830A1 Diaminotriazole compounds useful as protein kinase inhibitors
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
06/06/2007EP1791543A2 Triazolophthalazines
06/06/2007EP1378267B1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency
06/06/2007EP1373270B1 Tricyclic quinoxaline derivatives as a uv filter
06/06/2007EP0894620B1 Near infrared ray absorption film and multi-layered panel including same
06/06/2007DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids
06/06/2007CN1976935A Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
06/06/2007CN1976934A Alkyl substituted indoloquinoxalines
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
06/06/2007CN1976905A Pyrimidine derivatives and methods of treatment related to the use thereof
06/06/2007CN1976706A Inhibition of FGFR3 and treatment of multiple myeloma
06/06/2007CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
06/06/2007CN1974577A Process of synthesizing copper phthalocyanine in ionic liquid
06/06/2007CN1974573A Branchy porphyrin molecule with the characteristics of intramolecular energy transfer and two-photon absorption
06/06/2007CN1974572A Porphyrin derivative and its prepn process and use
06/06/2007CN1974571A Microwave assisted process of synthesizing tetraphenyl porphyrin inside ionic liquid
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1319974C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
06/06/2007CN1319973C Piperidine derivatives
06/06/2007CN1319952C Method for preparing oxazolidone amine
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders
06/05/2007US7227019 Low cost, simple, high yield and purity synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles; oxidative cyclization of bisindolylmaleimide compounds
06/05/2007US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents
06/05/2007US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
06/05/2007US7226922 Imidazo[1,2-b]pyridazine analogues as anxiolytics and cognition enhancers
06/05/2007US7226915 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
05/2007
05/31/2007WO2007061978A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061880A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061878A2 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
05/31/2007WO2007061764A2 Tricyclic compounds useful as inhibitors of kinases
05/31/2007WO2007061696A2 Spirolactam bicyclic cgrp receptor antagonists
05/31/2007WO2007061695A2 Bicyclic spirohydantoin cgrp receptor antagonists
05/31/2007WO2007061694A2 Spirohydantoin tricyclic cgrp receptor antagonists
05/31/2007WO2007061692A2 Spirolactam tricyclic cgrp receptor antagonists
05/31/2007WO2007061677A2 Spirolactam aryl cgrp receptor antagonists
05/31/2007WO2007061676A2 Spirohydantoin aryl cgrp receptor antagonists
05/31/2007WO2007060821A1 Bicyclic cinnamide compound
05/31/2007WO2007060404A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/31/2007WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia
05/31/2007WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/31/2007WO2007027651A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
05/31/2007WO2007014214A3 Introverted cucurbituril compounds
05/31/2007WO2006004937A3 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123546 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases
05/31/2007US20070123535 3-Amino-1-arylpropyl azaindoles and uses thereof
05/31/2007US20070123534 N-(3-Fluoro-4-(5-methyl-6-(2-(4-methylpiperazin-1-yl)ethoxy)pyrrolo[2,1 -f][1,2,4]triazin-4-yloxy)phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide; inhibit protein tyrosine kinase activity of epithelial growth factor receptors; angiogenesis inhibitor, anticarcinigenic; breast cancer
05/31/2007US20070123510 Guanidine derivatives
05/31/2007US20070123509 Carboxamide derivatives
05/31/2007US20070123494 Pyridopyrazine derivatives and their use
05/31/2007US20070122725 Method for preparing oxytitanium phthalocyanine chartge generating material and apparatus for preparing the same
05/31/2007US20070122444 Medical devices employing triazine compounds and compositions thereof
05/31/2007CA2630562A1 Tricyclic compounds useful as inhibitors of kinases
05/31/2007CA2630271A1 Fused bicyclic mtor inhibitors